focus -WSS

focus

author：Wikipedia 2025-09-29 22:50:51 - browse：76149

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Physician assistants need a new name. Here's what it should be

entertainment

hotspot

WSS

STAT Summit: GSK CEO on pharma giant's new direction

How climate

Allen Institute goes after foundational questions, CEO Costa says

Studies point to risks of excluding people with obesity from drug trials

Allen Institute goes after foundational questions, CEO Costa says

Why health workers in Gaza are injured or die at high rates

hotspot

focus

focus

How to save PrEP access — and even expand it

Eli Lilly expects to double planned employment in Boston center

Heart attack and stroke risk calculators need revising

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Alkermes shareholders re

Stories you might have missed in 2023: health, science, medicine

At least 13 dead in Texas as scorching temps continue

Physician assistants need a new name. Here's what it should be

Affirmative action in medical school literally saved lives

Medicare Advantage coverage denials need scrutiny, senators say

hotspot

The explosion of genetic testing requires a new approach

FDA gives detailed accounting of AI

Does Paxlovid work in people vaccinated against Covid

The EU Joint Clinical Assessment needs to live up to its promise

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

STAT Summit: Michael J. Fox on progress in Parkinson's research

entertainment

hotspot

Wikipedia

hotspot